ClinicalTrials.Veeva

Menu

Restrictive Versus Liberal Red Blood Cell Transfusion in Patients of Cirrhosis With Septic Shock

I

Institute of Liver and Biliary Sciences, India

Status

Withdrawn

Conditions

Cirrhosis

Treatments

Biological: Liberal
Other: Restrictive

Study type

Interventional

Funder types

Other

Identifiers

NCT03433508
ILBS-cirrhosis-01

Details and patient eligibility

About

Consecutive cirrhotics who present to emergency department of ILBS with documented or suspected sepsis induced hypotension with Hb <8 gm/dl will be randomly assigned to restrictive (Target Hb 7-8 gm/dl) to liberal (Target Hb 10-11 gm/dl) group in a 1:1 proportion At admission, all patients will undergo physical examination and baseline investigations to identify site of sepsis. Enrolled patients will be given PRBC-transfusion (Not more than two units of PRBC/day) when they reach their assigned trigger value (Hb 7-8 g/dl or 10-11 g/dl ) during the entire ICU stay. All other interventions will be at the discretion of clinicians.

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Cirrhosis with septic shock.
  2. Age >18 years

Exclusion criteria

  1. Previous severe adverse reaction with blood products,
  2. Disseminated intravascular coagulopathy
  3. HCC
  4. Pregnancy
  5. Malignancy
  6. Active gastrointestinal bleeding
  7. Intracranial bleeding
  8. Chronic Kidney disease with Maintenance Hemodialysis
  9. Pulmonary Edema
  10. Congestive Heart Failure
  11. Lack of informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Liberal
Experimental group
Description:
2 PRBC /day to maintain the target of Hemoglobin 10 to 11 gm/dL. PRBC will be given intravenously at least for 28 days
Treatment:
Biological: Liberal
Restrictive
Active Comparator group
Description:
To maintain the target Hemoglobin of 7 to 8 gm/dL.
Treatment:
Other: Restrictive

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems